Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Results from the Swiss mammography screening pilot programme.

J-L Bulliard1, J-P De Landtsheer, F Levi

  • 1Unité d'épidémiologie du cancer, Institut universitaire de médecine sociale et préventive, rue du Bugnon 17, 1005 Lausanne, Switzerland. Jean-Luc.Bulliard@inst.hospvd.ch

European Journal of Cancer (Oxford, England : 1990)
|July 31, 2003
PubMed
Summary

The first Swiss mammography screening pilot program demonstrated feasibility and acceptability, achieving quality standards and improving screening performance over time. This initiative successfully contributed to the wider implementation of breast cancer screening in Switzerland.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic syndrome and the risk of breast cancer in postmenopausal women.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

European cancer mortality predictions for the year 2011.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases.

The British journal of surgery·2011
Same author

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis.

Medical oncology (Northwood, London, England)·2010
Same author

Variation in performance in low-volume mammography screening programmes: experience from Switzerland.

Cancer epidemiology·2010
Same author

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.

British journal of cancer·2010

Area of Science:

  • Public Health
  • Oncology
  • Radiology

Background:

  • The Swiss healthcare system previously relied on opportunistic screening for breast cancer.
  • Organized screening programs were being explored to improve population health outcomes.
  • Mammography screening aims to detect breast cancer at earlier, more treatable stages.

Purpose of the Study:

  • To assess the feasibility and acceptability of an organized mammography screening program in Switzerland.
  • To evaluate the performance indicators of the first Swiss mammography screening pilot program.
  • To determine the impact of organized screening on breast cancer detection rates and patient outcomes.

Main Methods:

  • A biennial mammography screening program was conducted for women aged 50-69 in western Switzerland (canton of Vaud) from 1993 to 1998.

Related Experiment Videos

  • Approximately 15,000 women participated in the pilot program.
  • Key performance indicators including referral rates, specificity, and cancer detection rates were analyzed.
  • Main Results:

    • The program met most quality standard recommendations for mammography screening.
    • Referral rates for further assessment were 4.6% (prevalent) and 2.3% (incident), with high negative predictive values (84.7%/75.6%).
    • High specificity (96.1%/98.2%) and cancer detection rates (7.0/1000 and 5.9/1000) were observed, with screening performance improving over time and with age.

    Conclusions:

    • The organized mammography screening pilot program was feasible and acceptable within the Swiss healthcare context.
    • The program's success supported the subsequent implementation of screening in additional Swiss cantons.
    • Findings highlight the importance of organized screening programs in improving breast cancer detection and management.